Global Life Science Analytics Market is estimated to be US$ 48.63 billion by 2030 with a CAGR of 7.50% during the forecast period Life science analytical is the software used to overcome data integration, unpredictable demand and to enhance operational efficiency in the pharmaceutical and life science companies. They helps to standardize the clinical trials data and also validates its adherence. Advanced analytical aids are in early detection of potential risk and also enables to proactively address them. Life Science Analytics are ensures patient safety and also maintains regulatory compliance. It helps in suggesting the ways to reduce the trial costs without data compromising and study requirement. Life science analytics are contain Analytics module and Risk module. It ensures patient safety and maintains regulatory compliance and also helps in suggesting ways to reduce the trial costs without compromising data and study requirements. It has an Analytics module and an Integrated Risk Module.